Question: During the pandemic, should management of infants born to HBV-infected women continue?

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Obstetrical Care
What guidance is available for labor and delivery HCP with potential exposure in a healthcare setting to patients with COVID-19 infection?
section_content: HCP in labor and delivery healthcare settings should follow the same infection
prevention and control recommendations and personal protective equipment
recommendations as all other HCP. If HCP are exposed to patients with COVID-19
infection, guidance is available for HCP and healthcare facilities on steps to
take. For more information, please see: Interim U.S. Guidance for Risk
Assessment and Public Health Management of Healthcare Personnel with Potential
Exposure in a Healthcare Setting to Patients with Coronavirus Disease
(COVID-19)

Reviewer feedback on this answer:
Answer refers to HCP as opposed to HBV. Answer also refers to labor and delivery settings and not pediatrics.
Both talk about labor, but the information in the question and the answer are on different conditions.  I don't think this answer would help.

Reviewer ratings:
Bad
Could be Improved

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: COVID-19 Risk
Are pregnant healthcare personnel at increased risk for adverse outcomes if they care for patients with COVID-19?
section_content: Pregnant healthcare personnel (HCP) should follow risk
assessment and
infection control guidelines for HCP exposed to patients with suspected or
confirmed COVID-19. Adherence to recommended infection prevention and control
practices is an important part of protecting all HCP in healthcare settings.
Information on COVID-19 in pregnancy is very limited; facilities may want to
consider limiting exposure of pregnant HCP to patients with confirmed or
suspected COVID-19, especially during higher risk procedures (e.g., aerosol-
generating procedures) if feasible based on staffing availability.

Reviewer feedback on this answer:
Answer references HCP and pregnant patients in particular when query was directed towards the infant already being born. No mention of HBV.
The conditions mentioned appear to be different.  I'm not sure that the information here would help the person that is asking.

Reviewer ratings:
Bad
Could be Improved

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Patients with Liver Disease
Should management of infants born to HBV-infected women continue during the COVID-19 pandemic?
section_content: Yes. Management should continue to prevent mother-to-child transmission of
hepatitis B.
Pediatric Care of HBV-exposed Infants

Make every effort to ensure HBV-exposed infants complete the hepatitis B vaccine series following the ACIP recommendations (see https://www.cdc.gov/mmwr/volumes/67/rr/rr6701a1.htm). Providers using single-component vaccine who are experiencing immunization service disruption should administer hepatitis B vaccine as close to the recommended intervals as possible, including series completion at 6 months, and follow ACIP recommendations for post-vaccination serologic testing.
If post-vaccination serologic testing is delayed beyond 6 months after the hepatitis B series is completed, consider administering a “booster” dose of single antigen hepatitis B vaccine and then ordering post-vaccination serologic testing (HBsAg & antibody to HBsAg [anti-HBs]) 1-2 months after the “booster” dose.


Reviewer feedback on this answer:
Answer specifically refers to HBV-exposed infants as per the query and gives links for additional recommendations.
The answer addresses the condition specifically and also includes the fact that the woman is pregnant.  There is a decent amount of information.

Reviewer ratings:
Excellent
Excellent